In the light of the above, by interfering with LD biosynthesis, we investigated the effects of a DGAT2 inhibitor (PF-06424439) [28,29] in X-ray-irradiated MCF7 breast cancer cells in order to potentially affect breast cancer cell radioresistance. The gene discussed is DGAT2; the disease is breast carcinoma.